Danocrine Related Published Studies
Well-designed clinical trials related to Danocrine (Danazol)
Gestrinone versus danazol as preoperative treatment for hysteroscopic surgery: a prospective, randomized evaluation. [2006.04]
A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan. [2005.07]
Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. [2005.03]
Short-term postoperative GnRH analogue or danazol treatment after conservative surgery for stage III or IV endometriosis before ovarian stimulation: a prospective, randomized study. [2004.12]
An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis. [2004.06]
Reduced expression of alphavbeta3 integrin in the endometrium of unexplained infertility patients with recurrent IVF-ET failures: improvement by danazol treatment. [2003.01]
A randomized trial of danazol pretreatment prior to endometrial resection. [2002.06.10]
Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. [2002]
Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy. [2001.11]
Danazol mimics antigestagen action in first trimester termination of pregnancy. [2001.11]
Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. [2000.09.15]
A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis. [2000.06]
Low-dose danazol after combined surgical and medical therapy reduces the incidence of pelvic pain in women with moderate and severe endometriosis. [1999.09]
Effects of 3 month therapy with danazol after laparoscopic surgery for stage III/IV endometriosis: a randomized study. [1999.05]
Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol. [1999.01]
A double-blind randomised study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia. [1998.11]
Effect of danazol on the pregnancy rate in patients with unsuccessful in vitro fertilization-embryo transfer. [1998.06]
The effects of danazol after endometrial resection--results of a randomized, placebo-controlled, double-blind study. [1998.05]
Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. [1997.12]
Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis. [1996.08]
A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis. [1996.06]
A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation. [1996.04]
Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia. [1996.04]
Danazol versus a gonadotropin-releasing hormone agonist as preoperative preparation for hysteroscopic metroplasty. [1996.01]
The effect of danazol on discrete benign breast lumps. [1995.12]
The effect of regular exercise on women receiving danazol for treatment of endometriosis. [1995.06]
Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin. [1995.06]
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid. [1995.04]
Serum-soluble CD23 in patients with endometriosis and the effect of treatment with danazol and leuprolide acetate depot injection. [1995.04]
Short-term Lupron or danazol therapy for pelvic endometriosis. [1995.03]
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis. [1995.03]
A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. [1995]
Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study. [1994.12]
A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. [1994.10]
A Prospective Randomized Trial Comparing a GnRH Analog, Zoladex, and Danazol as Agents for Priming the Endometrium Prior to Endometrial Laser Ablation [1994.08]
Pain of endometriosis: effects of nafarelin and danazol therapy. [1994.07]
A review of 76 patients with myelodysplastic syndromes treated with danazol. [1994.06.15]
[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol] [1994.04]
A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. [1993.11]
Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. [1993.08]
Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group. [1993.07]
Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study. [1993.06]
Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. [1993.04]
The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial. [1993]
Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results. [1992.11]
Danazol in the treatment of menorrhagia: the effect of a 1 month induction dose (200 mg) and 2 month's maintenance therapy (200 mg, 100 mg, 50 mg or placebo). [1992.11]
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. [1992.10.17]
An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team. [1992.08]
On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol. [1992.05]
Danazol induces resistance to both insulin and glucagon in young women. [1992.02]
A randomized placebo-controlled double-blind study of danazol in hemophilia A. [1992]
Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans. [1991.11]
Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol. [1991.10]
Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones. [1991.10]
A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia. [1991.09]
Low dose danazol in the treatment of the premenstrual syndrome. [1991.05]
A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol. [1991.05]
Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: interaction with the effect of naloxone. [1991]
[Danazol in treatment of cystic mastopathy] [1991]
Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis. [1990.12]
Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis. [1990.10]
The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis. [1990.10]
A comparison of danazol and placebo in the treatment of adult idiopathic gynaecomastia: results of a prospective study in 55 patients. [1990.09]
The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis. [1990.09]
Endometrial patterns during danazol and buserelin therapy for endometriosis: comparative structural and ultrastructural study. [1990.07]
A comparison of nafarelin acetate and danazol in the treatment of endometriosis. [1990.06]
Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin. [1990.06]
Efficacy and safety of intranasal buserelin acetate in the treatment of endometriosis: a review of six clinical trials and comparison with danazol. [1990]
Buserelin versus danazol in the treatment of endometriosis-associated infertility. [1989.10]
Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. [1989.07]
Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol. [1989.06]
Comparison of cyproterone acetate and danazol in the treatment of pelvic pain associated with endometriosis. [1989.06]
Gestrinone versus danazol in the treatment of endometriosis. [1989.05]
A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis. [1989.03]
Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study. [1989.03]
Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. [1988.12]
The treatment of symptomatic benign breast disease with danazol. [1988.11]
Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study. [1988.09]
Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. [1988.02.25]
Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study. [1988.02]
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. [1987.12]
The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. [1987.07]
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. [1987.03]
The effectivenss of danazol on subsequent fertility in minimal endometriosis. [1982.11]
Well-designed clinical trials possibly related to Danocrine (Danazol)
[Observation on therapeutic effect of acupuncture and moxibustion on disorders of myometrial gland] [2008.08]
Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study. [2007.09]
[Controlled study on Shu-Mu point combination for treatment of endometriosis] [2006.12]
A randomised controlled trial of microwave endometrial ablation without endometrial preparation in the outpatient setting: patient acceptability, treatment outcome and costs. [2005.08]
Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials. [2002.06]
Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation. [2002.01]
Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. [2001.07]
Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium? [2000.09]
Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. [2000.08]
Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric. [1999.01]
Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci. [1999]
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes. [1998.05]
[Clinical observations on treatment of endometriosis by tonifying kidney and removing blood stasis] [1998.03]
A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. [1997.12]
Efficacy of isotopic 13CO2 laser laparoscopic evaporation in the treatment of infertile patients with minimal and mild endometriosis: a life table cumulative pregnancy rates study. [1997.02]
Is hormonal treatment efficacious in the management of ovarian cysts in women with histories of endometriosis? [1996.04]
[Hormonal premedication in endometrium ablation--results of a prospective comparative study] [1996]
|
